We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Notch Signaling Activity Controls Muscle Regeneration

By Biotechdaily staff writers
Posted on 10 Dec 2003
Print article
Researchers into aging have found that the Notch signaling pathway is critically involved in the decreased ability of muscles to regenerate after injury in older individuals.

The Notch signaling pathway is an evolutionarily highly conserved system for cell-cell communication, which exists in most if not all multicellular species. Notch receptors undergo a complex set of proteolytic processing events in response to ligand activating, which eventually leads to release of the intracellular domain of the receptor.


Investigators at Stanford University (Palo Alto, CA, USA) worked with a mouse model to examine the effect of the Notch pathway in muscle satellite cells. They found that the cells from older mice (equivalent to a 70-year-old human) did not reproduce as rapidly as those from younger animals, and that this was due to a decrease in synthesis of the Notch protein Delta.


They reported in the November 28, 2003, issue of Science that they could slow muscle regeneration in young cells by inhibiting Notch activity. On the other hand, older cells could be rejuvenated by treatment with a molecule that mimicked the activity of the Delta protein.

"What you really want to do is maintain the youthfulness of the regeneration pathway,” said senior author Dr. Thomas Rando, associate professor of neurology and neurological sciences at Stanford University. "If you presume that normal muscle bulk is maintained by gradual replacement of muscle tissue by satellite cells and that gradual replacement is diminished in older people, that would lead to atrophy. Figuring out atrophy in one of the pathways could relate to the others.”




Related Links:
Stanford University
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chagas Disease Test
LIAISON Chagas
New
Alpha-Fetoprotein Reagent
AFP Reagent Kit

Print article

Channels

Clinical Chemistry

view channel
Image: A one-step confirmatory laboratory test could definitively diagnose active syphilis infection within 10 minutes (Photo courtesy of Adobe Stock)

First Comprehensive Syphilis Test to Definitively Diagnose Active Infection In 10 Minutes

In the United States, syphilis cases have surged by nearly 80% from 2018 to 2023, with 209,253 cases recorded in the most recent year of data. Syphilis, which can be transmitted sexually or from mother... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more